Cargando…

Clinical significance of serum total oxidant/antioxidant status in patients with operable and advanced gastric cancer

PURPOSE: Oxidative stress was significantly associated with the development of malignancies. The purpose of this study was to evaluate the significance of serum total oxidant/antioxidant status in operable advanced gastric cancer patients. MATERIALS AND METHODS: A total of 284 patients who underwent...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Xue-Fang, Zhang, Li-Li, Zhang, De-Zhong, Yang, Lu, Fan, Ying-Ying, Dong, Shu-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187998/
https://www.ncbi.nlm.nih.gov/pubmed/30349309
http://dx.doi.org/10.2147/OTT.S153946
_version_ 1783363134970396672
author Du, Xue-Fang
Zhang, Li-Li
Zhang, De-Zhong
Yang, Lu
Fan, Ying-Ying
Dong, Shu-Ping
author_facet Du, Xue-Fang
Zhang, Li-Li
Zhang, De-Zhong
Yang, Lu
Fan, Ying-Ying
Dong, Shu-Ping
author_sort Du, Xue-Fang
collection PubMed
description PURPOSE: Oxidative stress was significantly associated with the development of malignancies. The purpose of this study was to evaluate the significance of serum total oxidant/antioxidant status in operable advanced gastric cancer patients. MATERIALS AND METHODS: A total of 284 patients who underwent curative resection for primary stage III gastric cancer were enrolled. Total oxidant status, total antioxidant status, and oxidative stress index (OSI) were evaluated within 24 hours before surgery, and compared with 120 healthy donors. The correlation between the OSI and survival outcome was analyzed by the Kaplan–Meier method with log-rank test and Cox’s regression methods, respectively. RESULTS: Mean OSI of gastric cancer patients was higher than healthy controls (1.41±0.96 vs 0.78±0.42, P<0.001). All patients were stratified into two groups using the optimal cutoff value (1.42) of OSI using a sensitivity of 94.1% and a specificity of 64.0% as optimal conditions from receiver operating curve analysis. Patients with an OSI ≥1.42 had poorer mean overall survival (45.6 vs 29.8 months, P=0.022) and mean recurrence-free survival (43.3 vs 28.1 months, P=0.011) than patients with an OSI <1.42 in univariate analysis, and OSI was also confirmed as an independent predictor for survival for gastric cancer in multivariate analysis (hazard ratio, 0.541; 95% CI: 0.127–1.102; P=0.01). CONCLUSION: Preoperative OSI can be considered as an independent prognostic factor for operable and advanced gastric cancer.
format Online
Article
Text
id pubmed-6187998
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61879982018-10-22 Clinical significance of serum total oxidant/antioxidant status in patients with operable and advanced gastric cancer Du, Xue-Fang Zhang, Li-Li Zhang, De-Zhong Yang, Lu Fan, Ying-Ying Dong, Shu-Ping Onco Targets Ther Original Research PURPOSE: Oxidative stress was significantly associated with the development of malignancies. The purpose of this study was to evaluate the significance of serum total oxidant/antioxidant status in operable advanced gastric cancer patients. MATERIALS AND METHODS: A total of 284 patients who underwent curative resection for primary stage III gastric cancer were enrolled. Total oxidant status, total antioxidant status, and oxidative stress index (OSI) were evaluated within 24 hours before surgery, and compared with 120 healthy donors. The correlation between the OSI and survival outcome was analyzed by the Kaplan–Meier method with log-rank test and Cox’s regression methods, respectively. RESULTS: Mean OSI of gastric cancer patients was higher than healthy controls (1.41±0.96 vs 0.78±0.42, P<0.001). All patients were stratified into two groups using the optimal cutoff value (1.42) of OSI using a sensitivity of 94.1% and a specificity of 64.0% as optimal conditions from receiver operating curve analysis. Patients with an OSI ≥1.42 had poorer mean overall survival (45.6 vs 29.8 months, P=0.022) and mean recurrence-free survival (43.3 vs 28.1 months, P=0.011) than patients with an OSI <1.42 in univariate analysis, and OSI was also confirmed as an independent predictor for survival for gastric cancer in multivariate analysis (hazard ratio, 0.541; 95% CI: 0.127–1.102; P=0.01). CONCLUSION: Preoperative OSI can be considered as an independent prognostic factor for operable and advanced gastric cancer. Dove Medical Press 2018-10-10 /pmc/articles/PMC6187998/ /pubmed/30349309 http://dx.doi.org/10.2147/OTT.S153946 Text en © 2018 Du et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php (http://https://www.dovepress.com/terms.php) and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (http://http://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Du, Xue-Fang
Zhang, Li-Li
Zhang, De-Zhong
Yang, Lu
Fan, Ying-Ying
Dong, Shu-Ping
Clinical significance of serum total oxidant/antioxidant status in patients with operable and advanced gastric cancer
title Clinical significance of serum total oxidant/antioxidant status in patients with operable and advanced gastric cancer
title_full Clinical significance of serum total oxidant/antioxidant status in patients with operable and advanced gastric cancer
title_fullStr Clinical significance of serum total oxidant/antioxidant status in patients with operable and advanced gastric cancer
title_full_unstemmed Clinical significance of serum total oxidant/antioxidant status in patients with operable and advanced gastric cancer
title_short Clinical significance of serum total oxidant/antioxidant status in patients with operable and advanced gastric cancer
title_sort clinical significance of serum total oxidant/antioxidant status in patients with operable and advanced gastric cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187998/
https://www.ncbi.nlm.nih.gov/pubmed/30349309
http://dx.doi.org/10.2147/OTT.S153946
work_keys_str_mv AT duxuefang clinicalsignificanceofserumtotaloxidantantioxidantstatusinpatientswithoperableandadvancedgastriccancer
AT zhanglili clinicalsignificanceofserumtotaloxidantantioxidantstatusinpatientswithoperableandadvancedgastriccancer
AT zhangdezhong clinicalsignificanceofserumtotaloxidantantioxidantstatusinpatientswithoperableandadvancedgastriccancer
AT yanglu clinicalsignificanceofserumtotaloxidantantioxidantstatusinpatientswithoperableandadvancedgastriccancer
AT fanyingying clinicalsignificanceofserumtotaloxidantantioxidantstatusinpatientswithoperableandadvancedgastriccancer
AT dongshuping clinicalsignificanceofserumtotaloxidantantioxidantstatusinpatientswithoperableandadvancedgastriccancer